Background: Interleukin-27 (IL-27) is a multifunctional cytokine with both pro-inflammatory and immunoregulatory functions. At present, the role of IL-27 in pulmonary fibrosis remains unknown.
Methods: In this study, we observed the expression of IL-27/IL-27R in a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. We verified the role of IL-27 using hematoxylin and eosin as well as Masson's staining methods and measuring the content of hydroxyproline as well as collagen I and III. We assessed the differentiation of T lymphocytes in the spleen and measured the concentration of cytokines in bronchoalveolar lavage fluid (BALF) and the expression level of relevant proteins in the JAK/STAT and TGF-beta/Smad signaling pathways in lung tissue.
Results: Increased IL-27 expression in BLM-induced pulmonary fibrosis was noted. IL-27 treatment may alleviate pulmonary fibrosis and increase the survival of mice. IL-27 inhibited the development of CD4(+) IL-17(+), CD4(+) IL-4(+) T, and CD4(+) Foxp3(+) cells and the secretion of IL-17, IL-4, IL-6, and TGF-beta. IL-27 induced the production of CD4(+) IL-10(+) and CD4(+) INF-gamma(+) T cells. IL-27 decreased the levels of phosphorylated STAT1, STAT3, STAT5, Smad1, and Smad3 but increased the level of SOCS3.
Conclusions: This study demonstrates that IL-27 potentially attenuates BLM-induced pulmonary fibrosis by regulating Th17 differentiation and cytokine secretion.
[1]Kunming Med Univ, Dept Resp, Affiliated Hosp 2, Kunming 650101, Yunnan, Peoples R China.
[2]Kunming Med Univ, Dept Hosp Serv, Affiliated Hosp 2, Kunming 650101, Yunnan, Peoples R China.
[3]Kunming Med Univ, Dept Sci Res & Postgrad Educ, Affiliated Hosp 2, Kunming 650101, Yunnan, Peoples R China.
[4]Kunming Med Univ, Dept Clin Lab, Yunnan Mol Diagnost Ctr, Affiliated Hosp 2, Kunming 650101, Yunnan, Peoples R China.
(8.0+极速模式)